EGFR and lung cancer: We found that BEZ235 suppressed cancer cell proliferation and the growth of lung cancer tumors regardless of their EGFR status by downregulating cyclin D members through both transcriptional inhibition and proteasome-mediated degradation (Fig. 7a).